Tech Company Financing Transactions
AltrixBio Funding Round
AltrixBio, based in Lowell, secured $5 million from private investors.
Transaction Overview
Company Name
Announced On
9/16/2025
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the clinical entry of AJN 003 (LuCI -- Luminal Coating of the Intestine), an oral therapy designed to transform the treatment of type 2 diabetes and metabolic diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Lowell, MA 01852
USA
Lowell, MA 01852
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
To transform the treatment of type 2 diabetes and obesity with a non-systemic, well-tolerated oral therapy that replicates the metabolic benefits of bariatric surgery without the burden of an invasive operation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Pass
Browse more venture capital transactions:
Prev: 9/16/2025: Microamp venture capital transaction
Next: 9/16/2025: Silent Push venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs